SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.11 Cr | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹0.34 Cr |
| Mar2023 | ₹0.25 Cr |
| Mar2022 | ₹0.46 Cr |
| Mar2021 | ₹0.43 Cr |
How is Deferred Tax Assets / Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | -66.96 | |
| Mar2024 | ₹0.34 Cr | 32.28 | |
| Mar2023 | ₹0.25 Cr | -44.90 | |
| Mar2022 | ₹0.46 Cr | 6.47 | |
| Mar2021 | ₹0.43 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹66.9 Cr | 4.2% | -0.2% | -36.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 4.2% |
-0.2% |
-36.8% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses